More recently, a LDCT screening study for primarily non-smoking Asian women, the demographic commonly associated with EGFR mutant LUAD, found an increase in cancer incidence in early-stage cancers (stages 0-I) yet no change in late-stage incidence (stages II-IV) (83). The gene discussed is EGFR; the disease is cancer.